Liu Xiao Lei

2001 9 -2008 6,2015 9 -2020 6.: 2008 8 -2012 12,2013 1 -2014 6 •,2014 7 -2019 6 •,2019 7 -2022 2 •,2022 3 - •.: “ ”1, “ ”1, “ ” 3, “ ”2.: 50, SCI 20, 70. 、 1 0 SCI,,. 5: 1. LiuX,ZhouR,SiS,LiuL,YangS,HanD,TanH.Sirolimuscombinedwithinterferon-alpha2btherapyforgianthepaticepithelioidhemangioendothelioma:acasereport. FrontOncol. 2022 Aug24;12:972306. 2. LiuX,YuH,ZhangZ,SiS,HuangJ,TanH,TengF,YangZ.MRIappearancesofhepaticepithelioidhemangioendothelioma:aretrospectivestudyof57patients. InsightsImaging. 2022 Apr5;13(1):65. 3. LiuX,ZhouR,SiS,LiuL,YangS,HanD,TanH.Casereport:Successfultreatmentwiththecombinedtherapyofinterferon-alpha2bandanlotinibinapatientwithadvancedhepaticepithelioidhemangioendothelioma. FrontMed(Lausanne). 2022 Dec2;9:1022017. 4. LiuX,QinH,TanH.GiantAbdominalCystCausedbyIntraductalPapillaryNeoplasmoftheBileDuct. JGastrointestSurg. 2022 Sep20.doi:10.1007/s11605-022-05447-1.Epubaheadofprint.PMID:36127554. 5. Liu X,ZhangZ,etal.Efficacyandsafetyofinterferon-alpha2bforpatientswithhepaticepithelioidhemangioendothelioma:outcomesofacase-seriesanalysis. CancerManagRes. 2021;13:8273-8279 6. Liu X,YangZ.Outcomesofhepaticepithelioidhemangioendotheliomawithdifferentmanagements:aretrospectiveinvestigation. EurRevMedPharmacolSci. 2021;25(12):4274-4282. 7. LiuX,HuangJ,LiuL,etal.MPZL1ishighlyexpressedinadvancedgallbladdercarcinomaandpromotestheaggressivebehaviorofhumangallbladdercarcinomaGBCSDcells. MolMedRep. 2019;20(3): 2 725-2733 8. LiuX,YangZ*,TanH,XuL,LiuL,HuangJ,SiS,SunY,ZhouW.Patientageaffectsthegrowthofliverhaemangioma. HPB(Oxford). 2018;20(1):64-68. 9. LiuX,HuangJ,TanH,YangZ*.Hemobiliacausedbypancreaticarteriovenousmalformation. Medicine ( Baltimore ). 2018;97(50):e13285 10. LiuX,YangZ*,TanH,ZhouW,SuY.FeverofUnknownOriginCausedbyGiantHepaticHemangioma. JGastrointestSurg. 2018;22(2):366-367. 11. LiuX,YangZ*,TanH,etal.Characteristicsandoperativetreatmentofextremelygiantliverhemangioma>20cm. Surgery. 2017;161(6):1514-1524 12. LiuX,YangZ*,TanH,etal.Locationaffectsthemanagementofliverhaemangioma:Aretrospectivecohortstudy. IntJSurg. 2017;48:110-115. 13. LiuX,YangZ*,TanH,etal.Long-termresultoftranscatheterarterialembolizationforliverhemangioma.Medicine.2017;96(49):e9029 14. LiuX,YangZ,etal.GiantliverhemangiomawithadultKasabach-Merrittsyndrome:Casereportandliteraturereview. Medicine(Baltimore). 2017;96(31):e7688.:: 2017,2014.